Bionano Genomics
BNGO
140 hedge funds and large institutions have $146M invested in Bionano Genomics in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 44 reducing their positions, and 20 closing their positions.
121% more call options, than puts
Call options by funds: $6.56M | Put options by funds: $2.96M
29% more capital invested
Capital invested by funds: $114M → $146M (+$32.9M)
0% less ownership
Funds ownership: 0.05% → 0.05% (-0%)
2% less funds holding
Funds holding: 143 → 140 (-3)
15% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 20
23% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 44
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$2.35M |
| 2 |
BlackRock
New York
|
+$1.31M |
| 3 |
Morgan Stanley
New York
|
+$690K |
| 4 |
D.E. Shaw & Co
New York
|
+$589K |
| 5 |
Goldman Sachs
New York
|
+$342K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$4.95M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.77M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$1.7M |
| 4 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
-$1.42M |
| 5 |
Two Sigma Investments
New York
|
-$712K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BRWA
151
B. Riley Wealth Advisors
Boca Raton,
Florida
| – | -$20K | -24 | Closed |
|
|
DC
152
Diametric Capital
Boston,
Massachusetts
| – | -$19K | -23 | Closed |
|
|
OIA
153
OneDigital Investment Advisors
Overland Park,
Kansas
| – | -$17K | -21 | Closed |
|
|
WANY
154
Wealthspire Advisors (New York)
New York
| – | -$16K | -19 | Closed |
|
|
OSAM
155
O'Shaughnessy Asset Management
Stamford,
Connecticut
| – | -$15K | -18 | Closed |
|
|
BFAG
156
Blackston Financial Advisory Group
The Villages,
Florida
| – | -$16K | -17 | Closed |
|
|
LWM
157
Laidlaw Wealth Management
New York City,
New York
| – | -$14K | -17 | Closed |
|
|
RFM
158
Royal Fund Management
Lady Lake,
Florida
| – | -$13K | -17 | Closed |
|
|
AIP
159
Ahrens Investment Partners
Lafayette,
Louisiana
| – | -$2K | -2 | Closed |
|
160
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$2K | -2 | Closed |
|
|
CAL
161
Capital Advisors Ltd
Shaker Heights,
Ohio
| – | -$1.32K | -1 | Closed |
|
BNGO Hedge Fund Activity: Q3 2022 in Review
140 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q3 2022, worth a combined $146M — up 29% from $114M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of BNGO and 17 opened new positions — a net loss of 3 holders — while 44 trimmed existing stakes and 34 added.
The largest buyer was State Street, adding an estimated $2.35M. The largest seller was Renaissance Technologies, cutting an estimated $4.95M.
- 140 institutional investors held Bionano Genomics (BNGO) as of Q3 2022, down from 143 in Q2 2022.
- Funds reported $146M of Bionano Genomics stock for Q3 2022, up 29% quarter-over-quarter.
- 17 funds opened new Bionano Genomics positions in Q3 2022 and 20 closed out, a net change of -3 holders.
- The largest Bionano Genomics buyer in Q3 2022 was State Street, an estimated $2.35M added.
- The largest Bionano Genomics seller in Q3 2022 was Renaissance Technologies, an estimated $4.95M sold.
Based on aggregated 13F filings for Q3 2022.